跳至主要内容
临床试验/JPRN-UMIN000041001
JPRN-UMIN000041001招募中未知

Perioperative glycemic control with insulin glargine 300 U/mL versus insulin degludec for surgical patients with type 2 diabetes in non-intensive care unit - PREMIER-INSULIN study

Graduate School of Medicine, Nippon Medical School0 个研究点目标入组 180 人开始时间: 2020年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have at least one of the following are excluded from the study. 1. Patients who are discharged from the hospital the day after surgery (for example, patients who undergo prostate biopsy or cataract surgery) 2.Patients who are using preoperative steroids or who are scheduled to use steroids during and after surgery. 3. Patients with or suspected of having active infection 4. Patients with diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome. 5. Patients with or suspected of being allergic to insulin glargine U-300 or insulin degludec 6. Pregnant women or women who may be pregnant, or breast-feeding patients 7. Patients who participated in another clinical study within 4 months before the start of the study. 8. Patients who are judged to be unsuitable for participation in this study by the investigator or the subinvestigator.

研究者

发起方
Graduate School of Medicine, Nippon Medical School

相似试验